Andere Sprachen Collegium Pharmaceutical, Inc.

Aktien

A14SUV

US19459J1043

COLL

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
36,42 ^USD	+1,62 %		+4,54 %	+18,32 %

11.04.	Collegium Pharmaceutical kündigt vorrangige Anleihen im Wert von $26,35 Millionen	MT
26.02.	COLLEGIUM PHARMACEUTICAL, INC. : Piper Sandler bekräftigt seine Kaufempfehlung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024	25.04.
Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes	11.04.
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026	11.04.
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026	11.04.
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference	03.04.
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference	03.04.
Collegium Pharmaceutical's Q4 Adjusted Earnings, Revenue Increase	23.02.
Collegium Pharmaceutical: Q4 Earnings Snapshot	22.02.
Earnings Flash (COLL) COLLEGIUM PHARMACEUTICAL Reports Q4 EPS $1.58, vs. Street Est of $1.26	22.02.
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results	22.02.
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results	22.02.
Collegium Pharmaceutical, Inc. Reaffirms Earnings Guidance for the Full Year 2024	22.02.
Collegium Pharmaceutical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22.02.
Collegium Pharmaceutical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22.02.
Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024	08.02.
Deadline Dexterity: PTAB Has Authority To Issue Decisions After Statutory Deadline	18.01.
North American Morning Briefing : Bond Yields Rise -2-	05.01.
North American Morning Briefing: S&P 500 Futures Nudge Higher After Weak Start to the Year	04.01.
Health Care Dips on Defensive Rotation - Health Care Roundup	03.01.
Collegium Pharmaceutical Expects Net Product Revenue of up to $595 Million in 2024	03.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Collegium Pharmaceutical, Inc.

Aktien

A14SUV

US19459J1043

COLL

Andere Sprachen

Filter